| abstract |
The present invention relates to methods for identifying agents capable of inducing respiratory sensitization in mammals, as well as arrays and diagnostic kits for use in such methods. Specifically, the method comprises measuring the expression levels of the biomarkers listed in Table A (i), Table A (ii), and / or Table A (iii) in cells exposed to the test drug. Including. [Selection] Figure 1 |